LTR Pharma (ASX: LTP)

Last close As at 20/03/2026

AUD0.40

−0.02 (−4.82%)

Market capitalisation

AUD72m

LTR Pharma is a commercial-stage pharmaceutical company delivering innovative therapies for significant unmet medical needs through its proprietary intranasal drug delivery platform.

Latest Insights

Healthcare | Quickview

LTR Pharma — Sizable upside potential for intranasal delivery

Sector

Healthcare

Equity Analyst

Jyoti Prakash

Jyoti Prakash, CFA

Director, healthcare

Key Management

  • Jacques Schipper

    CFO

  • Lee Rodne

    Executive Chairman